Discover how the p41 flagellin band plays a crucial role in Lyme disease testing, especially in Western blot diagnostics. Learn about modern advancements that enhance test accuracy, reduce cross-reactivity, and lead to more reliable diagnoses for better patient outcomes.
The LymeCare Alliance calls attention to a hidden health crisis impacting millions in Europe, as EU governments have ignored a 2018 resolution urging action on Borrelia, a bacterial infection affecting up to 25% of the population. Misdiagnosis and outdated testing protocols leave patients untreated and disabled, with healthcare systems failing to adopt accurate diagnostic methods. Unlike the U.S., where testing limitations for Lyme disease are disclosed, European patients are often misled, even when tests are positive.
This open letter urges political leaders and the media to expose this neglect and drive urgent reform to prevent further suffering and loss of life across the continent.
Lyme Disease can present a wide variety of symptoms. This comprehensive guide covers all possible signs and indicators to help with accurate recognition and diagnosis.
DualDur test redefines Lyme disease diagnosis by directly detecting Borrelia in the blood. Offering precise results in both early and chronic stages, this innovative method surpasses traditional testing, ensuring accurate diagnoses and better treatment outcomes for Lyme disease patients.
The Lymphocyte Transformation Test (LTT) for Lyme disease offers an alternative approach to diagnosing this complex infection. But does it live up to expectations? Explore the reliability, accuracy, and practical use of the LTT test to understand whether it’s the right diagnostic tool for Lyme disease.
